NASDAQ:CERC - Cerecor Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $3.57 -0.02 (-0.56 %) (As of 11/21/2018 03:11 AM ET)Previous Close$3.59Today's Range$3.40 - $3.7652-Week Range$1.17 - $5.74Volume86,900 shsAverage Volume166,229 shsMarket Capitalization$153.02 millionP/E Ratio8.50Dividend YieldN/ABeta1.48 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cerecor Inc., a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation. It also offers Karbinal ER, AcipHex Sprinkle, and Cefaclor for oral suspension; and Flexichamber. The company is developing CERC-301, an orphan neurological indication for controlling neurologic adaptation; CERC-611, a drug candidate for the treatment of partial-onset seizures in epilepsy; and two preclinical stage development candidates, CERC-406 and CERC-425 potential for the treatment of motoric and non-motoric symptoms of Parkinson's disease, as well as other psychiatric and neurological conditions. The company was formerly known as Ceregen Corporation and changed its name to Cerecor Inc. in March 2011. Cerecor Inc. was founded in 2011 and is headquartered in Baltimore, Maryland. Receive CERC News and Ratings via Email Sign-up to receive the latest news and ratings for CERC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CERC Previous Symbol CUSIPN/A Webwww.cerecor.com Phone410-522-8707 Debt Debt-to-Equity Ratio0.74 Current Ratio0.74 Quick Ratio0.70 Price-To-Earnings Trailing P/E Ratio8.50 Forward P/E Ratio-6.49 P/E GrowthN/A Sales & Book Value Annual Sales$27.81 million Price / Sales5.24 Cash Flow$0.4542 per share Price / Cash7.86 Book Value$1.07 per share Price / Book3.34 Profitability EPS (Most Recent Fiscal Year)$0.42 Net Income$11.86 million Net Margins-241.29% Return on Equity-75.94% Return on Assets-29.05% Miscellaneous Employees38 Outstanding Shares40,810,000Market Cap$153.02 million OptionableOptionable Cerecor (NASDAQ:CERC) Frequently Asked Questions What is Cerecor's stock symbol? Cerecor trades on the NASDAQ under the ticker symbol "CERC." How were Cerecor's earnings last quarter? Cerecor Inc (NASDAQ:CERC) released its earnings results on Monday, August, 14th. The company reported ($0.14) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.15. The firm had revenue of $0.16 million for the quarter. Cerecor had a negative return on equity of 75.94% and a negative net margin of 241.29%. View Cerecor's Earnings History. When is Cerecor's next earnings date? Cerecor is scheduled to release their next quarterly earnings announcement on Monday, April 1st 2019. View Earnings Estimates for Cerecor. What guidance has Cerecor issued on next quarter's earnings? Cerecor updated its FY 2018 earnings guidance on Tuesday, November, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $18-20 million. Has Cerecor been receiving favorable news coverage? News articles about CERC stock have trended positive on Wednesday, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cerecor earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the stock's share price in the immediate future. Who are some of Cerecor's key competitors? Some companies that are related to Cerecor include NuCana (NCNA), Principia Biopharma (PRNB), Collegium Pharmaceutical (COLL), CymaBay Therapeutics (CBAY), Rocket Pharmaceuticals (RCKT), Ra Pharmaceuticals (RARX), Basilea Pharmaceutica (BPMUF), Arvinas (ARVN), Insys Therapeutics (INSY), Eidos Therapeutics (EIDX), Arcus Biosciences (RCUS), GlycoMimetics (GLYC), ChemoCentryx (CCXI), Innate Pharma (IPHYF) and Clementia Pharmaceuticals (CMTA). Who are Cerecor's key executives? Cerecor's management team includes the folowing people: Mr. Peter S. Greenleaf, CEO & Director (Age 48)Ms. Mariam E. Morris, Consultant (Age 50)Dr. Solomon H. Snyder, Founder and Chairman of Scientific Advisory Board (Age 79)Dr. Barbara S. Slusher, Founder and Member of Scientific Advisory Board (Age 53)Mr. Joseph M. Miller CPA, Chief Financial Officer Who are Cerecor's major shareholders? Cerecor's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Cambridge Investment Research Advisors Inc. (0.09%). Company insiders that own Cerecor stock include Armistice Capital Master Fund, Armistice Capital, Llc, Peter Greenleaf and Robert Jr Moscato. View Institutional Ownership Trends for Cerecor. Which institutional investors are buying Cerecor stock? CERC stock was bought by a variety of institutional investors in the last quarter, including Cambridge Investment Research Advisors Inc.. Company insiders that have bought Cerecor stock in the last two years include Armistice Capital Master Fund, Armistice Capital, Llc, Peter Greenleaf and Robert Jr Moscato. View Insider Buying and Selling for Cerecor. How do I buy shares of Cerecor? Shares of CERC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cerecor's stock price today? One share of CERC stock can currently be purchased for approximately $3.57. How big of a company is Cerecor? Cerecor has a market capitalization of $153.02 million and generates $27.81 million in revenue each year. The company earns $11.86 million in net income (profit) each year or $0.42 on an earnings per share basis. Cerecor employs 38 workers across the globe. What is Cerecor's official website? The official website for Cerecor is http://www.cerecor.com. How can I contact Cerecor? Cerecor's mailing address is 400 E. Pratt Street Suite 606, Baltimore MD, 21202. The company can be reached via phone at 410-522-8707 or via email at [email protected] MarketBeat Community Rating for Cerecor (NASDAQ CERC)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 102 (Vote Outperform)Underperform Votes: 97 (Vote Underperform)Total Votes: 199MarketBeat's community ratings are surveys of what our community members think about Cerecor and other stocks. Vote "Outperform" if you believe CERC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CERC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/21/2018 by MarketBeat.com StaffFeatured Article: What strategies should day traders use to execute a trade?